NewAge Industries is adding cleanrooms at its Pennsylvania headquarters.
NewAge Industries, the manufacturer of AdvantaPure high purity tubing products used in single-use systems for biopharmaceutical manufacturing, is expanding capacity at its headquarters facility in southeastern Pennsylvania, according to a July 6, 2021 press release. The project will add more than 3000-ft2 of ISO Class 7 certified cleanrooms to the existing site used to manufacture AdvantaFlex weldable and sealable tubing, AdvantaSil silicone tubing and reinforced hose, and molded single-use tubing assemblies. Anticipated to cost $2 million, the expansion is an extension of a $10 million project completed in 2018.
“We predicted that the expansion we did a few years ago would be all the space we’d need for many years, since it involved over forty-thousand square feet,” said Ken Baker, CEO of NewAge Industries, in the press release. “But no one anticipated the pandemic. Business is robust, and we need more production and assembly rooms. … We’re hiring, we’re improving our processes, and we’re renovating another building that we purchased last year. The additional cleanrooms at our headquarters will help us get more, much-needed product out the door and on the way to our biopharm and pharmaceutical customers.”
The new rooms will be used primarily for the molding and assembly of AdvantaFlex products, including BioClosure container closures, molded tubing connections and assemblies, and tubing sets with various filters, fittings, bottles, and bags. The project is designed and is being constructed by AES Clean Technology of Montgomeryville, Pa., and it is expected to be completed during the third quarter of 2021.
Source: NewAge Industries
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.